FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127254785> ?p ?o ?g. }

• W2127254785 endingPage "781" @default.
• W2127254785 startingPage "777" @default.
• W2127254785 abstract "Background Half of patients with chronic heart failure (CHF) have preserved left-ventricular ejection fraction (LVEF), but few treatments have specifically been assessed in such patients. In previous studies of patients with CHF and low LVEF or vascular disease and preserved LVEF, inhibition of the renin-angiotensin system is beneficial. We investigated the effect of addition of an angiotensin-receptor blocker to current treatments. Methods Between March, 1999, and July, 2000, we randomly assigned 3023 patients candesartan (n=1514, target dose 32 mg once daily) or matching placebo (n=1509). Patients had New York Heart Association functional class II–IV CHF and LVEF higher than 40%. The primary outcome was cardiovascular death or admission to hospital for CHF. Anaysis was done by intention to treat. Findings Median follow-up was 36·6 months. 333 (22%) patients in the candesartan and 366 (24%) in the placebo group experienced the primary outcome (unadjusted hazard ratio 0·89 [95% Cl 0·77–1·03], p=0·118; covariate adjusted 0·86 [0·74–1·0], p=0·051). Cardiovascular death did not differ between groups (170 vs 170), but fewer patients in the candesartan group than in the placebo group were admitted to hospital for CHF once (230 vs 279, p=0·017) or multiple times. Composite outcomes that included non-fatal myocardial infarction and non-fatal stroke showed similar results to the primary composite (388 vs 429; unadjusted 0·88 [0·77–1·01], p=0·078; covariate adjusted 0·86 [0·75–0·99], p=0·037). Interpretation Candesartan has a moderate impact in preventing admissions for CHF among patients who have heart failure and LVEF higher than 40%. Published online Sept 1, 2003 http://image.thelancet.com/extras/03art7419web.pdf" @default.
• W2127254785 created "2016-06-24" @default.
• W2127254785 creator A5008402827 @default.
• W2127254785 creator A5014449865 @default.
• W2127254785 creator A5018419311 @default.
• W2127254785 creator A5020758622 @default.
• W2127254785 creator A5027213857 @default.
• W2127254785 creator A5028660133 @default.
• W2127254785 creator A5031560506 @default.
• W2127254785 creator A5037002715 @default.
• W2127254785 creator A5085843860 @default.
• W2127254785 date "2003-09-01" @default.
• W2127254785 modified "2023-10-11" @default.
• W2127254785 title "Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial" @default.
• W2127254785 cites W180946569 @default.
• W2127254785 cites W1980567021 @default.
• W2127254785 cites W2033989169 @default.
• W2127254785 cites W2056893352 @default.
• W2127254785 cites W2076008670 @default.
• W2127254785 cites W2098780362 @default.
• W2127254785 cites W2118046716 @default.
• W2127254785 cites W2133217116 @default.
• W2127254785 cites W2135038122 @default.
• W2127254785 cites W2154370947 @default.
• W2127254785 cites W2166193862 @default.
• W2127254785 cites W2945068164 @default.
• W2127254785 cites W3021063182 @default.
• W2127254785 cites W3023522280 @default.
• W2127254785 cites W4293085726 @default.
• W2127254785 doi "https://doi.org/10.1016/s0140-6736(03)14285-7" @default.
• W2127254785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13678871" @default.
• W2127254785 hasPublicationYear "2003" @default.
• W2127254785 type Work @default.
• W2127254785 sameAs 2127254785 @default.
• W2127254785 citedByCount "2531" @default.
• W2127254785 countsByYear W21272547852012 @default.
• W2127254785 countsByYear W21272547852013 @default.
• W2127254785 countsByYear W21272547852014 @default.
• W2127254785 countsByYear W21272547852015 @default.
• W2127254785 countsByYear W21272547852016 @default.
• W2127254785 countsByYear W21272547852017 @default.
• W2127254785 countsByYear W21272547852018 @default.
• W2127254785 countsByYear W21272547852019 @default.
• W2127254785 countsByYear W21272547852020 @default.
• W2127254785 countsByYear W21272547852021 @default.
• W2127254785 countsByYear W21272547852022 @default.
• W2127254785 countsByYear W21272547852023 @default.
• W2127254785 crossrefType "journal-article" @default.
• W2127254785 hasAuthorship W2127254785A5008402827 @default.
• W2127254785 hasAuthorship W2127254785A5014449865 @default.
• W2127254785 hasAuthorship W2127254785A5018419311 @default.
• W2127254785 hasAuthorship W2127254785A5020758622 @default.
• W2127254785 hasAuthorship W2127254785A5027213857 @default.
• W2127254785 hasAuthorship W2127254785A5028660133 @default.
• W2127254785 hasAuthorship W2127254785A5031560506 @default.
• W2127254785 hasAuthorship W2127254785A5037002715 @default.
• W2127254785 hasAuthorship W2127254785A5085843860 @default.
• W2127254785 hasConcept C126322002 @default.
• W2127254785 hasConcept C127413603 @default.
• W2127254785 hasConcept C142724271 @default.
• W2127254785 hasConcept C164705383 @default.
• W2127254785 hasConcept C204787440 @default.
• W2127254785 hasConcept C207103383 @default.
• W2127254785 hasConcept C27016395 @default.
• W2127254785 hasConcept C27081682 @default.
• W2127254785 hasConcept C2778198053 @default.
• W2127254785 hasConcept C2779611605 @default.
• W2127254785 hasConcept C2780036600 @default.
• W2127254785 hasConcept C2780645631 @default.
• W2127254785 hasConcept C2908929049 @default.
• W2127254785 hasConcept C44249647 @default.
• W2127254785 hasConcept C500558357 @default.
• W2127254785 hasConcept C71924100 @default.
• W2127254785 hasConcept C78085059 @default.
• W2127254785 hasConcept C78519656 @default.
• W2127254785 hasConcept C84393581 @default.
• W2127254785 hasConceptScore W2127254785C126322002 @default.
• W2127254785 hasConceptScore W2127254785C127413603 @default.
• W2127254785 hasConceptScore W2127254785C142724271 @default.
• W2127254785 hasConceptScore W2127254785C164705383 @default.
• W2127254785 hasConceptScore W2127254785C204787440 @default.
• W2127254785 hasConceptScore W2127254785C207103383 @default.
• W2127254785 hasConceptScore W2127254785C27016395 @default.
• W2127254785 hasConceptScore W2127254785C27081682 @default.
• W2127254785 hasConceptScore W2127254785C2778198053 @default.
• W2127254785 hasConceptScore W2127254785C2779611605 @default.
• W2127254785 hasConceptScore W2127254785C2780036600 @default.
• W2127254785 hasConceptScore W2127254785C2780645631 @default.
• W2127254785 hasConceptScore W2127254785C2908929049 @default.
• W2127254785 hasConceptScore W2127254785C44249647 @default.
• W2127254785 hasConceptScore W2127254785C500558357 @default.
• W2127254785 hasConceptScore W2127254785C71924100 @default.
• W2127254785 hasConceptScore W2127254785C78085059 @default.
• W2127254785 hasConceptScore W2127254785C78519656 @default.
• W2127254785 hasConceptScore W2127254785C84393581 @default.
• W2127254785 hasIssue "9386" @default.
• W2127254785 hasLocation W21272547851 @default.
• W2127254785 hasLocation W21272547852 @default.

• next